HMGB1 Released from Nociceptors Mediates Inflammation
HMGB1 released from nociceptors mediates inflammation Huan Yanga,1,2, Qiong Zenga,1, Harold A. Silvermana, Manojkumar Gunasekarana, Sam J. Georgea, Alex Devarajana, Meghan E. Addorisioa, Jianhua Lia, Téa Tsaavaa, Vivek Shaha, Timothy R. Billiarb, Haichao Wangc, Michael Brinesa, Ulf Anderssond, Valentin A. Pavlova,e,f, Eric H. Changa,e,f, Sangeeta S. Chavana,e,f,2, and Kevin J. Traceya,e,f,2 aLaboratory of Biomedical Sciences, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030; bDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213; cInstitute of Molecular Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030; dDepartment of Women’s and Children’s Health, Karolinska Institute, Karolinska University Hospital, 17176 Stockholm, Sweden; eThe Elmezzi Graduate School of Molecular Medicine, Manhasset, NY 11030; and fDonald and Barbara Zucker School of Medicine at Hofstra University, Hempstead, NY 11549 Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved June 17, 2021 (received for review February 1, 2021) Inflammation, the body’s primary defensive response system to homeostatic mechanisms at the intersection of the nervous sys- injury and infection, is triggered by molecular signatures of mi- tem and immune system have a fundamental role in health by crobes and tissue injury. These molecules also stimulate specialized inhibiting inflammation (15–17). sensory neurons, termed nociceptors. Activation of nociceptors me- The nervous system inhibits inflammation by transmitting diates inflammation through antidromic release of neuropeptides antiinflammatory signals in the vagus nerve, which arises in the into infected or injured tissue, producing neurogenic inflammation.
[Show full text]